CAS 331753-56-1|potassium antimony tartrate hydrate
| Common Name | potassium antimony tartrate hydrate | ||
|---|---|---|---|
| CAS Number | 331753-56-1 | Molecular Weight | 475.01500 |
| Density | 2.607 | Boiling Point | / |
| Molecular Formula | C8H10KO13Sb | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS06, GHS09 | Signal Word | Danger |
Names
| Name | potassium,antimony(3+),2,3-dihydroxybutanedioate,hydrate |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 2.607 |
|---|---|
| Molecular Formula | C8H10KO13Sb |
| Molecular Weight | 475.01500 |
| Exact Mass | 473.88000 |
| PSA | 250.67000 |
| Water Solubility | Soluble in water. Insoluble in ethanol. |
Safety Information
| Symbol | GHS06, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H332-H411 |
| Precautionary Statements | P273-P301 + P310 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn,N |
| Risk Phrases | R20/22;R51/53 |
| Safety Phrases | S61 |
| RIDADR | UN1551 |
| RTECS | CC7350000 |
| Packaging Group | III |
| Hazard Class | 6.1 |
Articles2
More Articles| Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effect. Int. J. Pharm. 482(1-2) , 21-6, (2015) Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing sin... | |
| In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob. Agents Chemother. 53 , 5197-203, (2009) Diagnostic material from patients with leishmaniasis is generally available as promastigotes, and proper testing for susceptibility to first-line drugs by the intracellular amastigote assay is frequen... |
Synonyms
| MFCD00149437 |
| potassium antimony tartrate hydrate |
